In the span of 30 minutes, 29-year Merck veteran Eliav Barr can analogize drug development dealmaking to Reese's candy, call himself an 'old fart' when asked about career plans, get real about the ...

Keytruda's dominance as a mainstay in cancer immunotherapy isn’t threatened by an experimental Chinese drug, a top Merck ...

Merck (MRK) and Daiichi Sankyo (DSNKY) announce early results from a Phase 2 trial of lung cancer drug I-DXd, an antibody ...

Merck & Co has said it will not file its cholesterol drug anacetrapib with regulators, saying that trial results are not good enough for clinical filings. The news came in a brief statement ...

Merck’s cancer immunotherapy Keytruda is the drug industry’s biggest blockbuster, bringing in $25 billion in sales last year.

Merck's combination of a wide lineup of high-margin drugs and a pipeline of new drugs should ensure strong returns on invested capital over the long term. Further, following the divestment of the ...

She left the company a day after BenevolentAI announced an alliance with German group Merck, worth up to $594 million, to apply its AI platform to deliver small-molecule drugs across three ...

Although the Food and Drug Administration has not approved ... Take your pet immediately to an emergency vet. The Merck ...

which can prevent absorption of the drug. According to the Merck Veterinary Manual, doxycycline dosage for dogs is usually 5 to10 mg per kilogram of body weight. Depending on the condition being ...